Label: CLEAR REFLECTION COMPLEXION ACNE TREATMENT SERUM- salicylic acid 2% gel

  • NDC Code(s): 76348-685-02
  • Packager: Renu Laboratories, Inc.
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated October 30, 2023

If you are a consumer or patient please visit this version.

View All Sections
  • ACTIVE INGREDIENT

    2 percent Salicylic Acid

  • WARNINGS

    For external use only.

  • DO NOT USE

    Do not use this medication if you have very sensitive skin or if you are sensitive to salicylic acid.

  • WHEN USING

    Skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one medication at a time.

    Avoid contact with the eyes

    If contact occurs, rinse thoroughly with water

  • KEEP OUT OF REACH OF CHILDREN

    Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

  • DOSAGE & ADMINISTRATION

    Directions

    In the morning, after cleansing face, apply serum evenly and make sure all problem areas are treated. Mild tingling may occur. If bothersome dryness occurs, reduce application to once every other day.

  • INACTIVE INGREDIENT

    Cyclopentasiloxane, Dimethiconol, Isopropyl Alcohol, Octyldodecanol, Helianthus Annuus (Sunflower) Seed Oil, Dimethicone, Dihydroeugenol, Isoeugenyl, Cinnamal, Ethyl Vanilla.

  • PURPOSE

    Acne Treatment

  • INDICATIONS & USAGE

    Recommended use is in the morning after cleansing and before applying any makeup.

  • QUESTIONS

    Call Customer Service at 1 800 990 6552 or contact customerservice@dermamedics.com

  • PRINCIPAL DISPLAY PANEL

    CLEAR REFLECTION SERUM

  • INGREDIENTS AND APPEARANCE
    CLEAR REFLECTION COMPLEXION ACNE TREATMENT SERUM 
    salicylic acid 2% gel
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:76348-685
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID1.04 g  in 52 mL
    Inactive Ingredients
    Ingredient NameStrength
    CINNAMALDEHYDE (UNII: SR60A3XG0F)  
    ISOPROPYL ALCOHOL (UNII: ND2M416302)  
    SUNFLOWER OIL (UNII: 3W1JG795YI)  
    ISOEUGENYL ACETATE (UNII: 9DF21GI8W6)  
    ETHYL VANILLIN (UNII: YC9ST449YJ)  
    DIHYDROEUGENOL (UNII: A3XE712277)  
    CYCLOMETHICONE 5 (UNII: 0THT5PCI0R)  
    OCTYLDODECANOL (UNII: 461N1O614Y)  
    DIMETHICONOL (50000 CST) (UNII: R2285D73YT)  
    DIMETHICONE 12500 (UNII: D1R3R4B8M8)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:76348-685-0252 mL in 1 BOTTLE, PUMP; Type 0: Not a Combination Product10/30/2023
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM00610/30/2023
    Labeler - Renu Laboratories, Inc. (945739449)
    Establishment
    NameAddressID/FEIBusiness Operations
    Renu Laboratories, Inc.945739449manufacture(76348-685)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!